Amneal Pharmaceuticals, Ownership
| AMRX Stock | USD 8.38 0.01 0.12% |
Shares in Circulation | First Issued 2009-03-31 | Previous Quarter 319 M | Current Value 310 M | Avarage Shares Outstanding 111.2 M | Quarterly Volatility 61 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Amneal |
Amneal Stock Ownership Analysis
About 53.0% of the company shares are held by company insiders. The company has Price/Earnings (P/E) ratio of 230.5. Amneal Pharmaceuticals, recorded a loss per share of 0.86. The entity had not issued any dividends in recent years. Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey. Amneal Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 7000 people. For more info on Amneal Pharmaceuticals, Class please contact Chintu Patel at 908 947 3120 or go to https://amneal.com.Besides selling stocks to institutional investors, Amneal Pharmaceuticals, also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Amneal Pharmaceuticals,'s stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Amneal Pharmaceuticals,'s strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Amneal Pharmaceuticals, Quarterly Liabilities And Stockholders Equity |
|
Amneal Pharmaceuticals, Insider Trades History
About 53.0% of Amneal Pharmaceuticals, Class are currently held by insiders. Unlike Amneal Pharmaceuticals,'s institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Amneal Pharmaceuticals,'s private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Amneal Pharmaceuticals,'s insider trades
Amneal Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Amneal Pharmaceuticals, is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Amneal Pharmaceuticals, Class backward and forwards among themselves. Amneal Pharmaceuticals,'s institutional investor refers to the entity that pools money to purchase Amneal Pharmaceuticals,'s securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Nuveen Asset Management, Llc | 2024-06-30 | 2.5 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 2.1 M | Blackbarn Capital Partners Lp | 2024-06-30 | 2 M | Fosun International Ltd | 2024-09-30 | 1.7 M | Northern Trust Corp | 2024-09-30 | 1.6 M | Hennessy Advisors, Inc. | 2024-09-30 | 1.6 M | Charles Schwab Investment Management Inc | 2024-09-30 | 1.4 M | Goldman Sachs Group Inc | 2024-06-30 | 1.4 M | Woodline Partners Lp | 2024-06-30 | 1.3 M | Ubs Group Ag | 2024-06-30 | 21.8 M | Vanguard Group Inc | 2024-09-30 | 14.6 M |
Amneal Pharmaceuticals, Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Amneal Pharmaceuticals, insiders, such as employees or executives, is commonly permitted as long as it does not rely on Amneal Pharmaceuticals,'s material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Amneal Pharmaceuticals, insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Amneal Pharmaceuticals, Outstanding Bonds
Amneal Pharmaceuticals, issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Amneal Pharmaceuticals, uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Amneal bonds can be classified according to their maturity, which is the date when Amneal Pharmaceuticals, Class has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| Amkor Technology 6625 Corp BondUS031652BK50 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Amneal Pharmaceuticals, Corporate Filings
F4 | 22nd of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
10Q | 12th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 8th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Amneal Stock Analysis
When running Amneal Pharmaceuticals,'s price analysis, check to measure Amneal Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals, is operating at the current time. Most of Amneal Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.